1
Katalin Kariko, Drew Weissman: RNA containing modified nucleosides and methods of use thereof. The Trustees of the University of Pennsylvania, Riverside Law, October 2, 2012: US08278036 (63 worldwide citation)

This invention provides RNA, oligoribonucleotide, and polyribonucleotide molecules comprising pseudouridine or a modified nucleoside, gene therapy vectors comprising same, methods of synthesizing same, and methods for gene replacement, gene therapy, gene transcription silencing, and the delivery of ...


2
Katalin Kariko, Drew Weissman: RNA containing modified nucleosides and methods of use thereof. The Trustees of the University of Pennsylvania, Riverside Law, September 16, 2014: US08835108 (40 worldwide citation)

This invention provides RNA, oligoribonucleotide, and polyribonucleotide molecules comprising pseudouridine or a modified nucleoside, gene therapy vectors comprising same, methods of synthesizing same, and methods for gene replacement, gene therapy, gene transcription silencing, and the delivery of ...


3
Katalin Kariko, Drew Weissman: RNA containing modified nucleosides and methods of use thereof. The Trustees of the University of Pennsylvania, Riverside Law, April 8, 2014: US08691966 (40 worldwide citation)

This invention provides RNA, oligoribonucleotide, and polyribonucleotide molecules comprising pseudouridine or a modified nucleoside, gene therapy vectors comprising same, methods of synthesizing same, and methods for gene replacement, gene therapy, gene transcription silencing, and the delivery of ...


4
Han Cao, Jonas O Tegenfeldt, Stephen Chou, Robert H Austin: Gradient structures interfacing microfluidics and nanofluidics. Princeton University, Riverside Law, December 18, 2012: US08333934 (15 worldwide citation)

The present invention relates to a device for interfacing nanofluidic and microfluidic components suitable for use in performing high throughput macromolecular analysis. Diffraction gradient lithography (DGL) is used to form a gradient interface between a microfluidic area and a nanofluidic area. Th ...


5
John R Lau, W Blair Geho: Method of increasing the bioavailability of recombinant human insulin isophane in a patient. SDG, Riverside Law, September 4, 2012: US08257735 (13 worldwide citation)

The instant invention is drawn to a hepatocyte targeted composition comprising a mixture of free recombinant human insulin isophane and free Recombinant human regular insulin insulin and a mixture of recombinant human insulin isophane and Recombinant human regular insulin insulin associated with a w ...


6
Dean J Vastardis, Lou Vastardis: Liquid infusion process and method of brewing a beverage. Bkon, Riverside Law, November 19, 2013: US08586117 (7 worldwide citation)

A liquid infusion and/or brewing process is described. The process includes the steps of placing a desired amount of an infusion material into a chamber at atmospheric pressure, placing a desired amount of liquid into said chamber, sealing said chamber from the surrounding atmosphere, and applying a ...


7
Dean J Vastardis: Vacuum brewed beverage method. Riverside Law, February 26, 2013: US08383180 (7 worldwide citation)

The desired amount of coffee grounds, tea leaves, herbs or other beverage making material is placed in a chamber of glass vessel located on a moveable table top in its lowered position. The table top is then elevated until the upper edge of the vessel seals against a top seal. With the top sealed, t ...


8
Peter I Lelkes, Mengyan Li, Mark Mondrinos, Frank Ko: Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds. Drexel University, Riverside Law, November 1, 2011: US08048446 (4 worldwide citation)

Non-woven fibrous scaffolds made by electrospinning from the synthetic biodegradable polymer such as, for example, poly(lactic-co-glycolic acid) (PLGA) and natural proteins, such as, for example, gelatin (denatured collagen) and elastin and a method of making thereof.


9
Rinaldo Zurbriggen, Christian Moser, Andreas Kammer, Mario Amacker, Nicole Westerfeld, Silvia Rasi: Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof. Pevion Biotech, Riverside Law, February 5, 2013: US08367077 (4 worldwide citation)

The present invention relates to virosomes comprising hemagglutinin (HA) with improved fusion activity. Preferably, the HA comprised in said virosomes was derived from influenza virus produced in a cell line. The present invention also relates to compositions and a kit comprising the virosomes accor ...


10
Mark L Tykocinski, Marjaneh Razmara: Fn14/TRAIL fusion proteins and method of treating cancer. The Trustees of the University of Pennsylvania, Riverside Law, December 11, 2012: US08329657 (3 worldwide citation)

Fusion proteins which act on the TWEAK and TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, as well as other diseases such as alloimmune diseases and cancer.